References
- 1. Van’t Hof W, Liem A, de Boer J, et al. Zwolle Myocardial Infarction Study Group. Clini-cal value of 12-lead electrocardiogram after successful reperfusion therapy for acute myo-cardial infarction. Lancet. 1997;350:615-619.
- 2. Resnic FS, Wainstein MW, Lee MK, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003;145:42-46. doi: 10.1067/mhj.2003.36.10.1067/mhj.2003.36
- 3. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699-1705.
- 4. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no-reflow’ phenome-non: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.10.1161/01.CIR.93.2.223
- 5. Eitel I, Wöhrle J, Suenkel H, et al. Intracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Cardiac Magnetic Resonance Substudy of the AIDA STEMI Trial. J Am Coll Cardiol. 2013;61:1447-1454. doi: 10.1016/j.jacc.2013.01.048.10.1016/j.jacc.2013.01.048
- 6. Jolly SS, Cairns JA, Yusuf S, et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomized TOTAL trial. Lancet. 2015;387:127-135. doi: 10.1016/S0140-6736(15)00448-1.10.1016/S0140-6736(15)00448-1
- 7. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293:1063-1072. doi: 10.1001/jama.293.9.1063.10.1001/jama.293.9.1063
- 8. Kelbaek H, Terkelsen CJ, Helqvist S, et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol. 2008;51:899-905. doi: 10.1016/j.jacc.2007.10.047.
- 9. Soeda T, Higuma T, Abe N, et al. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture. Eur Heart J Cardiovasc Imaging. 2017;18:103-110. doi: 10.1093/ehjci/jev341.10.1093/ehjci/jev341
- 10. Brener SJ, Dizon JM, Mehran R, et al. Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial. Am Heart J. 2013;166:676-683. doi: 10.1016/j.ahj.2013.07.025.
- 11. De Lemos JA, Braunwald E. ST Segment Resolution as a Tool for Assessing the Efficacy of Reperfusion Therapy. J Am Coll Cardiol. 2001;38:1283-1294.10.1016/S0735-1097(01)01550-9
- 12. Iwakura K, Ito H, Takiuchi S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation. 1996;94:1269-1275.10.1161/01.CIR.94.6.1269
- 13. Okamura A, Ito H, Iwakura K, et al. Usefulness of a new grading system based on coronary flow velocity pattern in predicting outcome in patients with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol. 2005;96:927-932. doi: 10.1016/j.amjcard.2005.05.049.10.1016/j.amjcard.2005.05.049
- 14. Iwakura K, Ito H, Kawano S, et al. Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices. Eur Heart J. 2004;25:1526-1533. doi: 10.1016/j.ehj.2004.06.029.10.1016/j.ehj.2004.06.029
- 15. Kramer MC, Van der Wal AC, Koch KT, et al. Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation. 2008;118:1810-1816. doi: 10.1161/CIRCULATIONAHA.108.780734.10.1161/CIRCULATIONAHA.108.780734
- 16. Schwartz RS, Burke A, Farb A, et al. Microemboli and Microvascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death: Relation to Epicardial Plaque Histopathology. J Am Coll Cardiol. 2009;23:2167-2173. doi: 10.1016/j.jacc.2009.07.042.10.1016/j.jacc.2009.07.042
- 17. Patel N, Petraco R, Dall'Armellina E, et al. Zero-Flow Pressure Measured Immediately After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Provides the Best Invasive Index for Predicting the Extent of Myocardial Infarction at 6 Months: An OxAMI Study (Oxford Acute Myocardial Infarction). J Am Coll Cardiol Intev. 2015;8:1410-1421. doi: 10.1016/j.jcin.2015.04.029.
- 18. Sezer M, Umman B, Okcular I, Nisanci Y, Umman S. Relationship between microvascular resistance and perfusion in patients with reperfused acute myocardial infarction. J Interv Cardiol. 2007;20:340-350. doi: 10.1111/j.1540-8183.2007.00274.x.10.1111/j.1540-8183.2007.00274.x
- 19. Echavarría-Pinto M, Serruys PW, Garcia-Garcia HM, et al. Use of intracoronary physiology indices in acute coronary syndromes. Interventional Cardiology. 2015;7:5,483-495.
- 20. Westman PC, Lipinski MJ, Luger D, et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol. 2016;67:2050-2060. doi: 10.1016/j.jacc.2016.01.073.10.1016/j.jacc.2016.01.073
- 21. Qin T, Xie L and Chen MH. Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon. BMC Cardiovasc Disord. 2013;13:68. doi: 10.1186/1471-2261-13-68.10.1186/1471-2261-13-68
- 22. Sezer M. Oflaz H, Gören T, et al. Intracoronary Streptokinase after Primary Percutaneous Coronary Intervention. N Engl J Med. 2007; 356:1823-1834. doi: 10.1056/NEJMoa054374.10.1056/NEJMoa054374
- 23. Iancu A, Ober C, Bondor CI, Cadiş H. Microvascular effect of intracoronary eptifibatide in acute myocardial infarction. Cardiology. 2012;123:46-53. doi: 10.1159/000341197.10.1159/000341197